Barclays Lowers its Price Target on Hims & Hers Health, Inc. (HIMS) to $25 and Keeps an Overweight Rating
📰 Original Source
Read full article at Finance →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.